Greenyug Specialty Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.23 Cr
as on 16-11-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 290.73%
(FY 2023)
- Profit 40.57%
(FY 2023)
- Ebitda -5.32%
(FY 2023)
- Net Worth -472.87%
(FY 2023)
- Total Assets -74.44%
(FY 2023)
About Greenyug Specialty Chemicals India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shrinivas Hake and Sagar Gadewar serve as directors at the Company.
- CIN/LLPIN
U24230PN2012FTC145036
- Company No.
145036
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
07 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Greenyug Specialty Chemicals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Gadewar  | Director | 07-Mar-2012 | Current |
Shrinivas Hake  | Whole-Time Director | 11-Aug-2014 | Current |
Financial Performance of Greenyug Specialty Chemicals India.
Greenyug Specialty Chemicals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 290.73% increase. The company also saw a substantial improvement in profitability, with a 40.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 472.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenyug Specialty Chemicals India?
In 2023, Greenyug Specialty Chemicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kx2 Development Private LimitedActive 4 years 3 monthsShrinivas Hake and Sagar Gadewar are mutual person
Octavegreen Laboratories Private LimitedActive 3 years 5 monthsShrinivas Hake and Sagar Gadewar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Greenyug Specialty Chemicals India?
Unlock and access historical data on people associated with Greenyug Specialty Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenyug Specialty Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenyug Specialty Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
